Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Qiong Gan Image

      Qiong Gan, M.D., Ph.D

      Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

      About Qiong Gan

      I am a board certified cytopathologist, working as an assistant professor in the Department of Pathology at The University of Texas MD Anderson Cancer Center (MDACC). I completed my residency training in Pathology at the Mount Sinai Morningside and Mount Sinai West, NY and Surgical Pathology as well as Cytopathology fellowships before I joined the staff at MDACC in 2018. I have also finished my PhD study in Molecular Physiology and Medicine at University of Virginia. I am currently the director of cytopathology fellowship program. My research interests include diagnostic cytology, especially pancreatic and thyroid cytology, and the application of unique cytopathology material such as malignant fluid in cancer research.


      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2007University of Virginia, Charlottesville, Virginia, US, Molecular Physiology and Biological Physics, Ph.D
      1999Wuhan University School of Medicine, Wuhan, CN, MD

      Postgraduate Training

      2017-2018Clinical Fellowship, Cytopathology, University of Texas at MD Anderson Cancer Center, Houston, Texas
      2016-2017Clinical Fellowship, Surgical Pathology, University of Texas at MD Anderson Cancer Center, Houston, Texas
      2012-2016Clinical Residency, Anatomic Pathology and Clinical Pathology, St. Luke’s-Roosevelt Hospital- Beth Israel Medical Center, Mount Sinai Health, New York City, New York

      Licenses & Certifications

      2018Cytopathology, The American Board of Pathology
      2018Texas Medical Board License
      2016Anatomic Pathology and Clinical Pathology, The American Board of Pathology (AP/CP)

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2024

      Assistant Professor, Pathology, UT MD Anderson Cancer Center, Houston, TX, 2018

      Administrative Appointments/Responsibilities

      Fellowship Program Director, Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Fellowship Program Associate Director, Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2021

      Extramural Institutional Committee Activities

      Member, PRS Faculty Compensation & Benefit Advisory Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Editorial Activities

      Editor/Service on Editorial Board(s), Cytopathology, 2020 - Present

      Honors & Awards

      2024Education and Mentorship Advancement
      2023 - 2024Faculty Teaching Award
      2019 - 2020Oncologic Pathology Teaching Award
      2014 - 2015USCAP Junior Member Travel Award
      2009 - 2011American Heart Association Fellowship Award
      1995 - 1998Outstanding Medical Student Award

      Professional Memberships

      Houston Society of Clinical Pathologist

      2018 - Present

      American Society of Cytopathology

      2018 - Present

      United States and Canadian Academy of Pathology

      2014 - Present

      College of American Pathologists

      2014 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2025. Digital Cytopathology and AI in Education: A Comprehensive and Practical Framework. Conference. 73rd Annual Scientific Meeting of American Society of Cytopathology. St Louis, Missouri, US.
      2. 2025. Unmasking Hematopoietic Lesions: Diagnostic Challenges that Even Experienced Cytopathologists Can't Always Spot!. Conference. 73rd Annual Scientific Meeting of American Society of Cytopathology. St Louis, Missouri, US.
      3. 2023. Evaluation of the Diagnostic Rate of the Bethesda Category III/VI Ratio for Thyroid FNA and Interobserver Variability: A Multi-Disciplinary Cancer Center Experience. Conference. USCAP, US.
      4. 2023. Distinction of Grade 3 Pancreatic Neuroendocrine Tumor versus Carcinoma using Cytomorphologic Assessment of FNA Material: Is it Doable and Does Experience Matter?. Conference. USCAP, US.
      5. 2023. TRPS1 expression in metastatic mammary and non-mammary tumors of Mullerian and pulmonary origin by immunohistochemistry using cytology specimens. Conference. USCAP, US.
      6. 2023. Extramedullary Hematopoiesis in Body Cavity Fluids: A Rare and Overlooked Diagnosis in Cytology. Conference. USCAP, US.
      7. 2022. Comparison of TRPS1 and GATA3 Immunoperoxidase Staining Using Cytologic Smears in Entities Reportedly Positive for GATA3. Conference. USCAP, US.
      8. 2022. Incorporate A Unique Molecular Pathology Module into Cytopathology Fellowship Training in the Era of Precision Medicine. Conference. USCAP, US.
      9. 2022. Expression of TRPS1, SOX10 and GATA3 in Different Subtypes of Metaplastic Breast Carcinoma. Conference. USCAP, US.
      10. 2021. Evaluation of Bronchoalveolar Lavage Cytology in COVID-19 Patients. Conference. USCAP, US.
      11. 2020. Utility of Ultrasound-Guided Fine-Needle Aspiration of Neck Lymph Nodes for Initial Staging and Surveillance of Patients with Papillary Thyroid Cancer. Conference. USCAP, US.
      12. 2020. Adequacy Evaluation of Pancreatic Adenocarcinoma Specimen for Next-Generation Sequencing Test Acquired by Endoscopic Ultrasound-Guided Fine-Needle Aspiration and Fine-Needle Biopsy. Conference. USCAP, US.
      13. 2020. Immunocytochemical Staining Validation of Nuclear Staining Markers on Cytology Smears. Conference. USCAP, US.
      14. 2020. Insulinoma-associated Protein 1 (INSM1) Immunostaining in Various Types of Neuroendocrine Tumors on Fine-Needle Aspiration Smears. Conference. USCAP, US.
      15. 2020. Clinical and Cytopathological Features of Suspected Thyroglossal Duct Cysts and Neoplasms Arising from Them: A Large Series from a Referral Cancer Center. Conference. USCAP, US.
      16. 2019. Comparison of Cytological and Histological Diagnosis of Pancreatic Cystic Lesions in a Large Cancer Center. Conference. USCAP, US.
      17. 2018. On The Way To Milan: A Multi-Institutional Study On The Reporting Rates Of Salivary Gland Cytopathology. Conference. USCAP, US.
      18. 2018. NF-kB Expression is Increased in MMR-Deficient Endometrial Endometrioid Adenocarcinoma and is Associated With Increased Macrophage Infiltration at the Tumor Periphery. Conference. USCAP, US.
      19. 2018. Cytologic Evaluation of PET-CT Positive Lymph nodes in Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): Experience of a Large Cancer Center. Conference. USCAP, US.
      20. 2018. Prevalence and Significance of Indeterminate Cytopathology Results from Ultrasound-Guided Fine Needle Aspiration of Thyroid in a Large Referral Cancer Center. Conference. USCAP, US.
      21. 2018. One Large Tertiary-Referral Cancer Centers Institutional Experience with the Accuracy of Combined Intraoperative Radiologic and Gross Margin Assessment and Resultant Re-excision Rates in Breast Cancer Surgery. Conference. USCAP, US.
      22. 2017. Thyroid Fine-Needle Aspiration. Invited. Latin American MITIE, US.
      23. 2017. Immunohistochemical expression of SALL4 in undifferentiated endometrial carcinoma and correlation with outcome. Conference. USCAP, US.
      24. 2017. Molecular modifiers of hormone receptor action: decreased androgen receptor expression in Mismatch Repair Deficient endometrial endometrioid adenocarcinoma. Conference. USCAP, US.
      25. 2017. Molecular modifiers of the immune microenvironment in endometrial endometrioid adenocarcinoma: PTEN intact and MMR deficiency are associated with increased expression of the immunosuppressive signaling protein STAT6. Conference. USCAP, US.
      26. 2016. BRAF Mutation V600E Induces Expression Change of Signaling Transduction Molecules in Melanoma Cell Lines. Conference. USCAP, US.
      27. 2015. Ovarian metastasis of breast cancer is associated with specific characteristics. Conference. ASCP, US.
      28. 2015. Stathmin-1 distinguishes high-grade from low-grade cervical intraepithelial neoplasm and immature squamous metaplasia. Conference. USCAP, US.
      29. 2015. A mystery of small intestine meschymal tumor: GIST. Conference. A mystery of small intestine meschymal tumor: GIST, US.
      30. 2015. Myxoid stroma in angiomatoid fibrous histiocytoma: a diagnostic pitfall. Conference. CAP, US.
      31. 2015. A case of secondary angiosarcoma of the breast after breast conserving surgery and radiation: Review of radiologic and pathologic findings. Conference. Journal of Clinical Imaging Science, US.
      32. 2014. Breathing through swiss cheese: A Case Of Rare Cystic Lung Disease. Conference. Breathing through swiss cheese: A Case Of Rare Cystic Lung Disease, US.

      International Presentations

      1. 2026. Challenges and Diagnostic Pitfalls of Pancreas Fine-Needle Aspiration. Invited. CAPA Cytology Lecture Series, US.
      2. 2025. Lung Adenosquamous Carcinoma: A Diagnostic and Molecular Challenge on Cytology. Invited. Project ECHO (Extension for Community Healthcare Outcomes) to collaborate with Indonesia, US.
      3. 2025. Challenges and Diagnostic Pitfalls of Pancreas Cytology. Invited. UTMB Pathology Department Grand Round, US.
      4. 2024. ICC in Cytology: Current Status and Ongoing Challenges. Invited. European Congress of Cytology. Leipzig, DE.
      5. 2024. Diagnostic Challenges and Pitfalls of Pancreas Cytology. Invited. University of California, Irvine. Irvine, US.
      6. 2023. Unlocking the Potential of Immunostaining in Cytology: A Comprehensive Review. Invited. The International Academy of Cytology, US.
      7. 2023. Thyroid FNA: Bethesda Reporting,Diagnostic Pitfalls and Molecular Testing. Invited. DPLM. Houston, US.
      8. 2019. Urine Cytology. Invited. UT Houston Medical School. Houston, US.
      9. 2018. Adequacy of EBUS-TBNA Specimens for Mutational Analysis in Metastatic Non-Small Cell Lung Cancer. Conference. ECC, ES.
      Read More
      Less

      Grant & Contract Support

      Date: 2021 - 2022
      Title:Comparison of TRPS1 with GATA-3 Immunostaining Using Fine-Needle Aspiration Material
      Funding Source:MDACC DPLM Anatomic Pathology, Mentor Research Fund Award
      Role:PI
      Date: 2020 - 2021
      Title:Evaluation of Bronchoalveolar Lavage Cytology in COVID-19 Patients and Identification of Cell Types Infected by the Virus
      Funding Source:MDACC DPLM Fellows Research Grant&Award
      Role:PI
      Date: 2019 - 2020
      Title:Comparison of Insulinoma-associated Protein 1 (INSM1) with Other Neuroendocrine Markers in Different Type and Grade of Neuroendocrine Tumors Using Fine-Needle Aspiration Material
      Funding Source:MDACC DPLM Anatomic Pathology, Mentor Research Fund Award
      Role:PI
      Date: 2019 - 2021
      Title:Endoscopic Ultrasound-Guided Fine-Needle Aspiration-Derived Specimen of Pancreatic Ductal Adenocarcinoma may Provide Optional Material for Molecular Tests
      Funding Source:MDACC DPLM Anatomic Pathology Department
      Role:PI
      ID:Junior Faculty Seed grant
      Title:Quantifying Temporal Immunologic Changes with Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
      Funding Source:ARTIDIS
      Role:Collaborator

      Selected Publications

      Peer-Reviewed Articles

      1. Han, J, Ding, Y, Gan, Q, Sweeney, K, Huang, X, Hameed, N, Weissferdt, A, Wang, Y, Peng, Y, Sun, H. TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms. Hum Pathol 177, 2026. e-Pub 2026. PMID: 42398545.
      2. Gan Q. GATA3 and TRPS1 Expression in Follicular Dendritic Cell Sarcoma, 2026. e-Pub 2026. PMID: 42631924.
      3. Yamashita, K, Kwiatkowski, E, Sewastjanow-Silva, M, Rogers, JE, Yoshimura, K, Pizzi, M, Gan, Q, Li, JJ, Waters, R, Murphy, MB, Iwatsuki, M, Hofstetter, WL, Chen, A, Yuan, Y, Ajani, JA. Clinical Machine Learning Model for Predicting Pathological Complete Response in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma After Trimodality Therapy. Ann Surg Oncol 33(8):7133-7141, 2026. e-Pub 2026. PMID: 42002713.
      4. Fan, Y, Vykoukal, JV, Song, S, Pizzi, M, Zou, G, Yoshimura, K, Jin, J, Katayama, H, Calin, GA, Waters, R, Gan, Q, Wang, L, Hanash, S, Dhar, SS, Ajani, JA. Protocol for isolating patient-derived ascites cells and extracellular vesicles from gastric cancer peritoneal metastases. STAR Protocols 6(4), 2025. e-Pub 2025. PMID: 41105517.
      5. Ahmed, MS, Klippel-Almaraz, D, Amin, SE, Sura, GH, Kundu, UR, Yu, W, Stewart, JM, Gan, Q, Krishnamurthy, S. Utility of whole-slide imaging for rapid evaluation of thyroid FNA. Cancer Cytopathology 133(9), 2025. e-Pub 2025. PMID: 40889104.
      6. Song, S, Fan, Y, Zou, G, Huo, L, Kumar, J, Li, Y, Wang, R, Dai, E, Jin, J, Scott, AW, Shao, SH, Pizzi, M, Vykoukal, JV, Katayama, H, Hanash, S, Calin, GA, Zhang, X, Lee, MG, Wang, Z, Lo, Y, Gan, Q, Waters, R, Yin, F, Wang, L, Cheng, X, Ajani, JA, Dhar, SS. KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Cancer Letters 621, 2025. e-Pub 2025. PMID: 40189014.
      7. Thomas K, Trinh H, Fei A, Khazai L, Sun H, Gan QJ. Cytologic features of angiosarcoma in fluid specimens: A retrospective study of 22 cases. Cancer Cytopathol 133(3):e70004, 2025. e-Pub 2025. PMID: 39992713.
      8. Yoshimura K, Zou G, Fan Y, Yamashita K, Wang L, Wu J, Wang R, Shao S, Scott AW, Jin J, Pizzi MP, Yao X, Brown CA, Wang L, Gan Q, Waters RE, Yin F, Song S, Dhar SS, Ajani JA. HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Lett 610:217354, 2025. e-Pub 2025. PMID: 39603381.
      9. Fan Y, Song S, Pizzi MP, Zou G, Vykoukal JV, Yoshimura K, Jin J, Calin GA, Waters RE, Gan Q, Wang L, Hanash S, Dhar SS, Ajani JA. Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations. iScience 28(1):111564, 2025. e-Pub 2025. PMID: 39811647.
      10. Gan Q, Ding Y, Wu Y, Zhang Y, Meng QH, Ding QQ, Lu H, Shelburne SA, Ehlers RA 2nd, Han XY. Infections Due to Corynebacterium kroppenstedtii With Focus on Granulomatous Lobular Mastitis for Tissue Specificity, Pathogenesis, Bacteriologic Workup, and Treatment. Arch Pathol Lab Med 149(9):812-821, 2025. e-Pub 2025. PMID: 39800878.
      11. Mir, M, Soto, F, Gomez, PA, Arroyo, RR, Suresh, A, Su, A, Gan, Q, Stewart, J, Adachi, R, Balachandran, D, Bashoura, L, Casal, RF, Dickey, BF, Eapen, GA, Evans, S, Grosu, HB, Jimenez, C, Lin, J, Ost, D, Sabath, BF, Shannon, VR, Naing, A, Gao, J, Wu, J, Suresh, K, Faiz, S, Altan, M, Sheshadri, A. Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis. Frontiers in Medicine 12, 2025. e-Pub 2025. PMID: 40529125.
      12. Sakshi FNU, Mallikarjuna VS, Stewart JM, Gan Q. Extramedullary Hematopoiesis in Serous Cavity Fluids: A Closer Look at This Rare Phenomenon With Diagnostic Pitfalls and Prognostic Significance. Diagn Cytopathol 53(4):167-172, 2024. e-Pub 2024. PMID: 39704045.
      13. Davaro E, Rohra P, Kundu U, Gan Q. Bilateral Cystic Endosalpingiosis in Cervical Lymph Nodes Mimicking Metastatic Papillary Thyroid Carcinoma Morphologically on Cytology: A Case Report and Literature Review of Diagnostic Challenges. Diagn Cytopathol, 2024. e-Pub 2024. PMID: 39679640.
      14. Sewastjanow-Silva M, Kwiatkowski E, Yamashita K, Abdelhakeem A, Yoshimura K, Vicentini ER, Pizzi MP, Jin J, Fan Y, Zou G, Wang L, Yin F, Dhar SS, Blum Murphy M, Mares JE, Li JJ, Gan Q, Waters RE, Rogers JE, Ajani JA. Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience. Int J Cancer 155(12):2277-2286, 2024. e-Pub 2024. PMID: 38995150.
      15. Donthi D, Donthi D, Gan Q, Gan Q, Ding QQ, Ding QQ, Krishnamurthy S, Krishnamurthy S. Trichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Mullerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohistochemistry with cytology cell block specimens. Cancer Cytopathol 132(12):799-808, 2024. e-Pub 2024. PMID: 39264831.
      16. Hara, Y, Baba, Y, Oda, E, Harada, K, Yamashita, K, Toihata, T, Kosumi, K, Iwatsuki, M, Miyamoto, Y, Tsutsuki, H, Gan, Q, Waters, R, Komohara, Y, Sawa, T, Ajani, JA, Baba, H. Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers. British journal of cancer 131(5):797-807, 2024. e-Pub 2024. PMID: 38992099.
      17. Yamashita K, Sewastjanow-Silva M, Yoshimura K, Rogers JE, Rosa Vicentini E, Pool Pizzi M, Fan Y, Zou G, Li JJ, Blum Murphy M, Gan Q, Waters RE, Wang L, Ajani JA. SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel. Cancers (Basel) 16(7), 2024. e-Pub 2024. PMID: 38610978.
      18. Gong B, Li D, Zhang Y, Kusko R, Lababidi S, Cao Z, Chen M, Chen N, Chen Q, Chen Q, Dai J, Gan Q, Gao Y, Guo M, Hariani G, He Y, Hou W, Jiang H, Kushwaha G, Li JL, Li J, Li Y, Liu LC, Liu R, Liu S, Meriaux E, Mo M, Moore M, Moss TJ, Niu Q, Patel A, Ren L, Saremi NF, Shang E, Shang J, Song P, Sun S, Urban BJ, Wang D, Wang S, Wen Z, Xiong X, Yang J, Yin L, Zhang C, Zhang R, Bhandari A, Cai W, Eterovic AK, Megherbi DB, Shi T, Suo C, Yu Y, Zheng Y, Novoradovskaya N, Sears RL, Shi L, Jones W, Tong W, Xu J. Extend the benchmarking indel set by manual review using the individual cell line sequencing data from the Sequencing Quality Control 2 (SEQC2) project. Sci Rep 14(1):7028, 2024. e-Pub 2024. PMID: 38528062.
      19. Laberiano-Fernandez C, Gan Q, Wang SM, Tamegnon A, Wistuba I, Yoon E, Roy-Chowdhuri S, Parra ER. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma. J Am Soc Cytopathol 13(3):161-173, 2024. e-Pub 2024. PMID: 38519275.
      20. Fakhri NL, Gan Q. Desmoplastic Small Round Cell Tumor Involving Serous Fluid: Cytologic Features and Diagnostic Pitfalls A Series of 8 Cases. Am J Clin Pathol 160(4):417-424, 2023. e-Pub 2023. PMID: 37289439.
      21. Rodriguez JJ, Gan Q, Kundu U. A cytopathological tale of a pediatric renal tumor. Diagn Cytopathol 51(9):584-586, 2023. e-Pub 2023. PMID: 37338161.
      22. Lizarraga Madrigal D, Cabrera Charleston M, Khan A, Eapen G, Kalhor N, Gan Q, Grosu H. Pulmonary Sclerosing Pneumocytomas Mimicking Lung Cancer. Cureus 15(4):e37395, 2023. e-Pub 2023. PMID: 37182004.
      23. Najjar S, Gan Q, Stewart J, Sneige N. The utility of claudin-4 versus MOC-31 and Ber-EP4 in the diagnosis of metastatic carcinoma in cytology specimens. Cancer Cytopathol 131(4):245-253, 2023. e-Pub 2023. PMID: 36522809.
      24. Rohra P, Ding C, Yoon EC, Gan Q. A pilot study: Comparison of TRPS1 and GATA3 immunoperoxidase staining using cytologic smears in entities reportedly positive for GATA3. Cancer Cytopathol 130(12):930-938, 2022. e-Pub 2022. PMID: 35790088.
      25. Gan Q, Caraway NP, Ding C, Stewart JM. Primary Pancreatic Lymphoma Evaluated by Fine-Needle Aspiration. Am J Clin Pathol 158(2):242-248, 2022. e-Pub 2022. PMID: 35311939.
      26. Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum Pathol 125:97-107, 2022. e-Pub 2022. PMID: 35413381.
      27. Gan Q, Roy-Chowdhuri S, Duose DY, Stewart JM, Coronel E, Bhutani MS, Lee JH, Weston B, Ge PS, Ross WA, Maitra A. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB. Cancer Cytopathol 130(4):275-283, 2022. e-Pub 2022. PMID: 34905283.
      28. Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W, Solis Soto LM, Wang S, Wistuba II, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
      29. Hou T, Liu Z, Gan Q, Debnam JM, Krishnamurthy S. Clinical and cytopathological features of suspected thyroglossal duct cysts and neoplasms arising from them: A large series from a referral cancer center. Cancer Cytopathol 130(1):72-79, 2022. e-Pub 2022. PMID: 34529338.
      30. Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Blum Murphy M, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Song S, Wang L, Ajani JA. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70(11):2055-2065, 2021. e-Pub 2021. PMID: 33334899.
      31. Song S, Xu Y, Huo L, Zhao S, Wang R, Li Y, Scott AW, Pizzi MP, Wang Y, Fan Y, Harada K, Jin J, Ma L, Yao X, Shanbhag ND, Gan Q, Roy-Chowdhuri S, Badgwell BD, Wang Z, Wang L, Ajani JA. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma. J Exp Clin Cancer Res 40(1):207, 2021. e-Pub 2021. PMID: 34162421.
      32. Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol 34(4):710-719, 2021. e-Pub 2021. PMID: 33011748.
      33. Chin KE, Kwon D, Gan Q, Ramalingam PX, Wistuba II, Prieto VG, Aung PP. Transition From a Standard to a Hybrid On-Site and Remote Anatomic Pathology Training Model During the Coronavirus Disease 2019 (COVID-19) Pandemic. Arch Pathol Lab Med 145(1):22-31, 2021. e-Pub 2021. PMID: 32937659.
      34. Porteus C, Gan Q, Gong Y, Pantanowitz L, Henderson-Jackson E, Saeed-Vafa D, Mela N, Peterson D, Ahmad N, Ahmed A, Bui M. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases. J Am Soc Cytopathol 9(6):513-519, 2020. e-Pub 2020. PMID: 32624384.
      35. Hou T, Stewart JM, Lee JH, Gan Q. Solid Tumor Metastases to the Pancreas Diagnosed Using Fine-Needle Aspiration. Am J Clin Pathol 154(5):692-699, 2020. e-Pub 2020. PMID: 32651950.
      36. Hou T, Gan Q, Joseph CT, Sun X, Gong Y. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears. Cancer Cytopathol 128(10):725-732, 2020. e-Pub 2020. PMID: 32573984.
      37. Gan Q, Edeiken BS, Chen MM, Grubbs EG, Busaidy NL, Zafereo M, Perrier ND, Gule-Monroe MD, Krishnamurthy S. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center. J Am Soc Cytopathol 8(6):309-316, 2019. e-Pub 2019. PMID: 31526696.
      38. Gan Q, Stewart JM, Valik E, Eapen G, Caraway NP. Cytologic Evaluation of Positron Emission Tomography-Computed Tomography-Positive Lymph Nodes Sampled by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Experience at a Large Cancer Center. Arch Pathol Lab Med 143(10):1265-1270, 2019. e-Pub 2019. PMID: 31063012.
      39. Gan Q, Joseph CT, Guo M, Zhang M, Sun X, Gong Y. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol 152(4):495-501, 2019. e-Pub 2019. PMID: 31175351.
      40. Gan Q, Crumley S, Broaddus RR. Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma. Int J Gynecol Pathol 38(1):44-51, 2019. e-Pub 2019. PMID: 29210800.
      41. Eppelheimer CN, Marti JL, Eisenberg A, Gan Q, Shabalova R, Cohen JM, Fulop T. A Case of Secondary Angiosarcoma of the Breast after Breast-conserving Surgery and Radiation: Review of Radiologic and Pathologic Findings. J Clin Imaging Sci 5:45, 2015. e-Pub 2015. PMID: 26430538.
      42. Buono KD, Vadlamuri D, Gan Q, Levison SW. Leukemia inhibitory factor is essential for subventricular zone neural stem cell and progenitor homeostasis as revealed by a novel flow cytometric analysis. Dev Neurosci 34(5):449-62, 2012. e-Pub 2012. PMID: 23258129.
      43. Gan Q, Thiébaud P, Thézé N, Jin L, Xu G, Grant P, Owens GK. WD repeat-containing protein 5, a ubiquitously expressed histone methyltransferase adaptor protein, regulates smooth muscle cell-selective gene activation through interaction with pituitary homeobox 2. J Biol Chem 286(24):21853-64, 2011. e-Pub 2011. PMID: 21531708.
      44. Jin L, Gan Q, Zieba BJ, Goicoechea SM, Owens GK, Otey CA, Somlyo AV. The actin associated protein palladin is important for the early smooth muscle cell differentiation. PLoS One 5(9):e12823, 2010. e-Pub 2010. PMID: 20877641.
      45. Yoshida T, Gan Q, Franke AS, Ho R, Zhang J, Chen YE, Hayashi M, Majesky MW, Somlyo AV, Owens GK. Smooth and cardiac muscle-selective knock-out of Kruppel-like factor 4 causes postnatal death and growth retardation. J Biol Chem 285(27):21175-84, 2010. e-Pub 2010. PMID: 20439457.
      46. Deaton RA, Gan Q, Owens GK. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol 296(4):H1027-37, 2009. e-Pub 2009. PMID: 19168719.
      47. Cherepanova OA, Pidkovka NA, Sarmento OF, Yoshida T, Gan Q, Adiguzel E, Bendeck MP, Berliner J, Leitinger N, Owens GK. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 104(5):609-18, 2009. e-Pub 2009. PMID: 19168440.
      48. Yoshida T, Gan Q, Owens GK. Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol 295(5):C1175-82, 2008. e-Pub 2008. PMID: 18768922.
      49. Gan Q, Yoshida T, Li J, Owens GK. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res 101(9):883-92, 2007. e-Pub 2007. PMID: 17823374.
      50. Yoshida T, Gan Q, Shang Y, Owens GK. Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol 292(2):C886-95, 2007. e-Pub 2007. PMID: 16987998.

      Invited Articles

      1. Yu WD, Gan Q, Gong Y. The Yokohama System for Reporting Breast Cytopathology. Journal of Clinical and Translational Pathology, 2023. e-Pub 2023.
      2. Gan Q, Roy-Chowdhuri S. Specimen Considerations in Molecular Oncology Testing. Clin Lab Med 42(3):367-383, 2022. e-Pub 2022. PMID: 36150817.
      3. Chasen NN, Wang JR, Gan Q, Ahmed S. Imaging of Cervical Lymph Nodes in Thyroid Cancer: Ultrasound and Computed Tomography. Neuroimaging Clin N Am 31(3):313-326, 2021. e-Pub 2021. PMID: 34243866.

      Review Articles

      1. Li, JJ, Rogers, JE, Waters, R, Gan, Q, Blum Murphy, M, Ajani, JA. Evolution of Therapeutics for Locally Advanced Upper Gastrointestinal Adenocarcinoma. Cancers 17(8), 2025. e-Pub 2025. PMID: 40282483.
      2. Rogers JE, Gan Q, Waters RE, Horak AA, Ajani JA. Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-art. Expert Opin Biol Ther 24(10):1005-1015, 2024. e-Pub 2024. PMID: 39315517.
      3. Kundu U, Gan Q, Donthi D, Sneige N. The Utility of Fine Needle Aspiration (FNA) Biopsy in the Diagnosis of Mediastinal Lesions. Diagnostics (Basel) 13(14), 2023. e-Pub 2023. PMID: 37510144.
      4. Yu, W, Gan, Q, Gong, Y. The Yokohama System for Reporting Breast Cytopathology. Journal of Clinical and Translational Pathology 3(2):99-105, 2023. e-Pub 2023.
      5. Yu, W, Gan, Q, Gong, Y. The Yokohama System for Reporting Breast Cytopathology. Journal of Clinical and Translational Pathology 3(2):99-105, 2023. e-Pub 2023.
      6. Velez-Perez A, Abuharb B, Bammert CE, Landon G, Gan Q. Detection of non-haematolymphoid malignancies in bronchoalveolar lavages-A cancer centre's 10 year experience. Cytopathology 33(4):449-453, 2022. e-Pub 2022. PMID: 35077018.
      7. Gan Q, Roy-Chowdhuri S. Small but powerful: the promising role of small specimens for biomarker testing. J Am Soc Cytopathol 9(5):450-460, 2020. e-Pub 2020. PMID: 32507626.
      8. Gan Q, Yoshida T, McDonald OG, Owens GK. Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 25(1):2-9, 2007. e-Pub 2007. PMID: 17023513.

      Other Articles

      1. Mir, M, Soto, F, Gomez, PA, Arroyo, RR, Suresh, A, Su, A, Gan, Q, Stewart, J, Adachi, R, Balachandran, D, Bashoura, L, Casal, RF, Dickey, BF, Eapen, GA, Evans, S, Grosu, HB, Jimenez, C, Lin, J, Ost, D, Sabath, BF, Shannon, VR, Naing, A, Gao, J, Wu, J, Suresh, K, Faiz, S, Altan, M, Sheshadri, A Correction. Frontiers in Medicine 12, 2025. PMID: 40641984.

      Abstracts

      1. Gan Q. Utility of Whole Slide Imaging for Evaluation of Thyroid Fine Needle Aspiration: A Multi-reader Prospective Study. USCAP 113th Annual Meeting.
      2. Gan Q. Angiosarcoma in Fluids: A Review of Cytologic Features in 22 Patients. USCAP 113th Annual Meeting.

      Book Chapters

      1. Gan Q, Yang J, Heymann JJ, Roy-Chowdhuri S. Diagnostic category: Atypical. In: WHO Reporting System for Pancreaticobiliary Cytopathology. 1st. International Agency for Research on Cancer (IARC), 2023.

      Letters to the Editor

      1. Wang, WJ, Jeffrey Medeiros, L, Tang, G, Garces, S, Guo, CC, Gan, Q, Li, S, Lin, P, Wang, W, Xu, J. CD30+ High Grade Neoplasm With Expression of β-HCG and T-Cell Markers. Pathol Int 76: e70120, 2026.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 02, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top